All News

In a letter to CMS Administrator Seema Verma, Energy and Commerce Committee Chairman Frank Pallone Jr, D-New Jersey, and Ways and Means Committee Chairman Richard E. Neal, D-Massachusetts, have demanded information on the Trump administration’s changes to the federal marketplace, which they say can cause confusion for enrollees, weaken consumer protections, and further compromise the Affordable Care Act (ACA).

A pilot study is suggesting that ruxolitinib is safe and tolerable as maintenance therapy following allogeneic stem cell transplantation.

During the Center for Strategic & International Studies’ event “HIV/AIDS in the Unites States: The Road to 2030,” Anthony S. Fauci, MD, director of the National Institutes of Health’s National Institute of Allergy and Infectious Diseases, and Robert Redfield, MD, director, CDC, joined to explain why the country is ready and able to end the epidemic from both a policy and clinical perspective.

A recent joint American Thoracic Society and the European Respiratory Society statement urged policymakers and clinicians to take seriously the role that inhaled vapors, gas, dust, or fumes have in creating occupational respiratory disease.

The House Appropriation Committee has voted to uphold a ban on genetically modified babies; an assisted suicide bill was passed by the Maine Legislature and will head to the desk of Governor Janet Mills; Beverly Hills has become the first city in the United States to ban sales of tobacco and tobacco-related products.

Results from a new study show that most nicotine-dependent patients with chronic obstructive pulmonary disease (COPD) who attended a 3-month smoking cessation program at a single-center clinic in Japan were able to quit smoking.

Though chimeric antigen receptor (CAR) T-cell therapy has been largely touted as one of the most important advances in cancer care in recent years, the therapy comes with the risk of severe toxicities as well as increased financial burden due to the high cost of the drugs.

Outlining a set of issues that need to be addressed under the Oncology Care Model (OCM), the Community Oncology Alliance (COA) is urging the Center for Medicare & Medicaid Innovation to delay the October 2019 deadline for practices to transition to 2-sided risk under the model.

The government seeks make it easier for cancer patients to use experimental drugs; a federal judge says the FDA can regulate stem cell companies; US senators reveal a list of 400 troubled nursing homes.

Arbaclofen extended-release tablets were found to be a safe treatment that reduced spasticity in patients with multiple sclerosis.

The essay appears as 9 states have passed laws that are designed to provoke challenges to Roe v Wade before the Supreme Court of the United States.

People living with HIV are generally at 1.5- to 2-fold higher risk for cardiovascular diseases (CVDs), including heart attacks, strokes, and heart failure, and they often face barriers to accessing care.

Contrary to conventional wisdom, higher levels of genomic instability have been associated with lower immunogenicity, which means drugs are less effective, in patients with BRCA1/2-related breast cancers, according to research published in Clinical Cancer Research.

The authors, from the CDC, say that while the decline in diabetes incidence occurred alongside public health efforts, it's too soon to assume a causal relationship.

The Illinois Senate passed an abortion rights bill; a new study presented last weekend at ASCO 2019 found the Affordable Care Act (ACA) reduced racial disparites in cancer care; Johnson & Johnson has been ordered to pay an additional $300 million in NY talcum powder case.

Evidence suggests probiotics may decrease pro-inflammatory cytokines, oxidative stress, and potentially pathogenic bacterial overgrowth in patients with Parkinson disease.

Patients with multiple sclerosis who received natalizumab therapy had lower relapse rates and reduced inflammation.

Two abstracts at the 2019 American Society of Clinical Oncology Annual Meeting analyzed bone metastases in cancer.

Long-term use of ozanimod may be associated with improved cognitive speed and higher rates of no evidence of disease activity among patients with relapsing multiple sclerosis (MS), according to 2 new abstracts presented at the 33rd Annual Meeting of the Consortium of Multiple Sclerosis Centers.

According to a recent study, people with bipolar disorder were more likely to later develop Parkinson disease (PD) compared with patients who do not have the disorder.

This is part 3 of a 3-part vaccine series covering the potential of vaccines for infectious diseases, the impact of the antivaccination movement, and the promise of vaccines for cancer treatment. Read part 1 and part 2.

Creating a healthcare system that prioritizes a well-informed consumer and rewards improvements in quality requires overhauling the current system. Through a series of programs and initiatives, CMS, under Administrator Seema Verma’s leadership, is trying to fix some of the issues that plague the current US health system and make accessing care challenging for patients.

The addition of daratumumab to standard treatment of lenalidomide and dexamethasone for patients with multiple myeloma, who were ineligible for autologous stem-cell transplant, was found to significantly lower the risk of disease progression or death compared with those who only received standard treatment.

https://www.pharmacytimes.org/on-demand/managing-vasoocclusive-crisis-in-sickle-cell-disease-a-look-at-the-clinical-and-economic-burden

Lack of awareness of hypoglycemia symptoms can be dangerous, because the person with diabetes can experience a dangerous drop in blood sugar; chronic low blood glucose can result in complications.

https://www.pharmacytimes.org/on-demand/ajmc-payer-and-specialty-pharmacy-forum-improving-the-adoption-of-oncology-biosimilars-in-practice

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

Here are the top 5 articles for the month of May.